Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors

Abstract

Use of cholinesterase inhibitors is associated with increased rates of syncope, bradycardia, pacemaker insertion, and hip fracture in older adults with dementia. The risk of these previously underrecognized serious adverse events must be weighed carefully against the drugs' generally modest benefits.